Squamous cell carcinoma of head and neck – Life with Disease

Go back

Squamous cell carcinoma of the head and neck is a group of cancers that begin in the thin, flat cells lining the moist surfaces inside the mouth, throat, nose, and nearby structures. Understanding what lies ahead after diagnosis can help patients and their families prepare for the journey, manage expectations, and find the support they need during treatment and beyond.

Understanding Your Prognosis

When you receive a diagnosis of squamous cell carcinoma of the head and neck, one of the first questions that naturally comes to mind is about the future. Prognosis, which refers to the likely course and outcome of the disease, depends on many individual factors that your medical team will carefully evaluate[3].

The overall five-year survival rate for people with head and neck cancer is approximately sixty percent. This means that about six out of every ten people diagnosed with this type of cancer are still alive five years after their diagnosis[12]. However, it is important to remember that survival rates are statistics based on large groups of people, and your individual situation may be quite different.

Several factors influence prognosis significantly. The stage at which cancer is detected plays a crucial role—cancers found early, when they are still localized and have not spread to other areas, are generally much more treatable and have better outcomes. In fact, head and neck cancers detected in early stages are often highly curable, sometimes with just one type of treatment such as surgery or radiation alone[4].

Another important factor is whether the cancer is related to human papillomavirus, or HPV. HPV-positive head and neck cancers, which are increasingly common and often affect younger people, tend to have a more favorable prognosis compared to cancers caused by tobacco or alcohol use[12][4]. The exact location of the tumor within the head and neck region also matters, as does your overall health and ability to tolerate treatment.

If the cancer has spread to distant parts of the body, such as the lungs or other organs, the prognosis becomes more serious and the disease can be fatal. This is why early detection and prompt treatment are so important[3].

⚠️ Important
Survival statistics are averages based on many people and cannot predict what will happen in your specific case. Your healthcare team can provide more personalized information based on your unique situation, including the specific characteristics of your cancer, your age, overall health, and how well you respond to treatment.

Natural Progression Without Treatment

Understanding how squamous cell carcinoma of the head and neck develops and progresses naturally helps explain why treatment is so important. This type of cancer typically begins with changes in the cells lining the moist surfaces of the mouth, throat, or other head and neck structures[2].

The disease often follows a progression through several stages. It may start with cellular atypia, which means cells that look slightly abnormal under a microscope. Over time, these changes can advance through various degrees of dysplasia, a term that describes increasingly abnormal cell growth. Eventually, if left unchecked, these changes can develop into invasive cancer that has the ability to spread beyond its original location[4].

Interestingly, despite this pattern of progression, most patients are actually diagnosed with late-stage disease without doctors ever having identified an earlier precancerous lesion. This happens because the early changes may not cause noticeable symptoms, or they may be mistaken for less serious conditions[4].

When head and neck squamous cell carcinoma spreads, it almost always does so first to nearby areas and to the lymph nodes in the neck. Lymph nodes are small, bean-shaped structures that are part of the immune system. Sometimes, cancer cells are found in the lymph nodes of the neck even when doctors cannot locate where the cancer originally started in the head and neck region. When this happens, it is called metastatic squamous cell carcinoma with occult primary, meaning the original tumor is hidden or too small to detect[2][10].

Without treatment, the cancer continues to grow at its original site and may spread further. It can invade and destroy healthy tissues nearby, affecting structures that are critical for eating, breathing, and speaking. The cancer may eventually spread to distant organs such as the lungs, which significantly worsens the prognosis[3].

Possible Complications

Squamous cell carcinoma of the head and neck can lead to various complications, both from the disease itself and from the treatments used to fight it. These complications can be unexpected and may significantly impact quality of life, which is why close monitoring and supportive care are essential throughout the treatment journey.

One major concern is the cancer’s ability to spread to nearby structures. Because head and neck cancers occur in areas that are structurally complex and vital for survival, the tumor can interfere with basic functions. As it grows, it may make eating, chewing, drinking, breathing, or speaking increasingly difficult[17][14]. These functional difficulties can develop gradually or sometimes quite suddenly if the tumor grows rapidly.

The visible nature of head and neck cancer is another source of potential complications. Changes in appearance due to the disease itself or its treatment cannot easily be concealed. This visibility can lead to embarrassment and have a profound impact on a person’s social interactions, family relationships, and self-esteem[17][5].

Treatment-related complications are also significant. Surgery, radiation therapy, and chemotherapy—the main treatments for these cancers—can all cause side effects. Surgery may result in changes to facial structure or function. Radiation can cause skin changes, difficulty swallowing, changes in taste, and dry mouth. Chemotherapy may lead to fatigue, nausea, and increased risk of infection. Some patients experience poorly intelligible speech or drooling after treatment, which can be distressing and affect daily activities[17][14].

Complications can extend beyond physical symptoms. Many individuals with head and neck cancer experience significant psychosocial dysfunction, which refers to problems with mental health and social functioning. Studies have shown that patients place immense importance on being able to return to society in a meaningful way after treatment, and this concern can sometimes take priority even over fear of cancer recurrence[17].

The burden of psychiatric distress, including anxiety and depression, is substantial among newly diagnosed patients with head and neck cancer. The fear and uncertainty that accompany any cancer diagnosis are amplified by the specific challenges of head and neck cancer, making psychological support an important part of comprehensive care[17].

Impact on Daily Life

Living with squamous cell carcinoma of the head and neck affects virtually every aspect of daily life. The diagnosis itself, much like any cancer diagnosis, often comes as a devastating shock, producing a more alarming response than many other diseases. Patients suddenly find themselves on a difficult journey that disrupts their normal routines and is surrounded by fear and uncertainty[17].

The physical effects on daily activities can be profound. Eating and drinking, activities most people take for granted, can become major challenges. Some patients struggle with chewing food properly or swallowing safely. Changes in taste can make food less enjoyable or even unpalatable. For many, mealtimes transform from social occasions into sources of anxiety and frustration[17][5].

Communication is another area deeply affected. Speaking clearly may become difficult, whether due to the cancer itself or the effects of treatment. This can make simple conversations challenging and may cause people to withdraw from social situations. The voice box, or larynx, plays a crucial role in speech, and cancers affecting this area or its treatment can significantly alter how a person sounds[2][14].

Breathing can also be affected, particularly if the cancer involves the throat or voice box. Some patients experience shortness of breath or feel like they cannot get enough air, which is frightening and limits physical activity[5][14].

The visible nature of head and neck cancer creates unique social challenges. Unlike cancers that develop in internal organs, the effects of head and neck cancer and its treatment are often obvious to others. Patients may have noticeable swelling, surgical scars, or changes in facial appearance that they cannot hide. This visibility can lead to unwanted attention, questions, or stares from strangers, adding to the emotional burden[17].

Work life is frequently disrupted. The treatment process requires numerous medical appointments, procedures, and recovery time. Fatigue from treatment can make it difficult to maintain a regular work schedule. Additionally, if job responsibilities involve speaking, customer interaction, or physical exertion, these may become temporarily or permanently impossible to perform[17].

Emotional and mental health impacts are substantial. Many patients experience feelings of low self-esteem, particularly when they perceive changes in their appearance or functional abilities. Depression and anxiety are common. The diagnosis can strain relationships with family members and friends, even as patients need support more than ever. Some people find that their hobbies and interests no longer bring joy, or that they lack the energy or physical ability to participate in activities they once loved[17].

⚠️ Important
Psychosocial interventions, such as education combined with cognitive-behavioral therapy, have been shown to have an overall positive effect for people dealing with head and neck cancer. Seeking support from mental health professionals, support groups, or counseling services is not a sign of weakness but an important step in comprehensive care and recovery.

Despite these significant challenges, many patients develop coping strategies that help them adapt. Making adjustments to diet, such as eating softer foods or using nutritional supplements, can help maintain nutrition. Learning new communication strategies or using assistive devices can ease frustration with speech difficulties. Connecting with others who have experienced similar challenges through support groups can reduce feelings of isolation and provide practical tips for managing day-to-day life[17].

The concept of quality of life has gained increasing attention in head and neck cancer care. Healthcare providers now recognize that successful treatment means more than just eliminating cancer—it also means helping patients function within society in a meaningful way and maintaining the best possible quality of life throughout the treatment journey and beyond[17][4].

Support for Family Members

When someone is diagnosed with squamous cell carcinoma of the head and neck, it affects not just the patient but the entire family. Family members often want to help but may feel uncertain about what they can do or how to navigate the complex world of cancer treatment, including clinical trials.

Understanding clinical trials is an important first step. Clinical trials are research studies that test new treatments or new ways of using existing treatments. For head and neck cancer, clinical trials may investigate new chemotherapy drugs, innovative radiation techniques, immunotherapy approaches, or combinations of different treatments[9][12]. These studies are essential for advancing medical knowledge and improving outcomes for future patients.

For patients considering clinical trials, family members can provide valuable assistance in several ways. First, they can help gather and organize medical information. Clinical trial enrollment typically requires detailed medical history, test results, and documentation of the cancer diagnosis. Having this information compiled and easily accessible can streamline the application process.

Family members can also help research available clinical trials. Numerous databases exist where ongoing trials can be searched by cancer type, location, and specific criteria. This research can be time-consuming, and sharing this task reduces the burden on the patient, who may already be dealing with symptoms, medical appointments, and the emotional stress of the diagnosis[12].

Understanding eligibility criteria is crucial. Clinical trials have specific requirements about who can participate, based on factors such as the stage of cancer, previous treatments received, overall health status, and other medical conditions. Family members can help review these criteria and determine which trials might be appropriate options to discuss with the healthcare team.

Attending medical appointments together can be extremely helpful. Family members can take notes during discussions with doctors, ask questions the patient might not think of, and help remember information that was discussed. When emotions are high, it can be difficult to absorb and retain all the information provided, so having another person present ensures that important details are not missed.

If a patient decides to participate in a clinical trial, family support continues to be important. Clinical trials often require frequent visits to the medical center, careful tracking of symptoms and side effects, and strict adherence to the study protocol. Family members can help with transportation to appointments, keeping records of medications and symptoms, and noticing changes that should be reported to the medical team.

Emotional support is equally important. The decision to join a clinical trial can bring up feelings of hope, but also anxiety about the unknown. Some patients worry about receiving a placebo or not receiving standard treatment. Family members can provide reassurance, help weigh the potential benefits and risks, and respect the patient’s ultimate decision about whether to participate.

Practical assistance with daily tasks becomes increasingly important as treatment progresses. Help with household chores, meal preparation, childcare, or financial management can significantly reduce stress for the patient. Even small gestures like accompanying the patient to appointments or simply being present to listen can make a meaningful difference.

Family members should also remember to take care of themselves. Caring for someone with cancer is emotionally and physically demanding. Seeking support through caregiver support groups, talking with friends, or working with a counselor can help family members maintain their own wellbeing so they can continue to provide effective support[20].

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Cetuximab (Erbitux®) – A monoclonal antibody that targets the EGFR pathway, approved for subsets of patients with advanced head and neck cancer, including as a first-line therapy, and generally used in combination with radiation when comorbidities prevent the use of cytotoxic chemotherapy[4][9][12].
  • Pembrolizumab (Keytruda®) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway, approved by the FDA for treatment of recurrent or metastatic head and neck squamous cell carcinoma and as primary treatment for unresectable disease[4][9][12].
  • Nivolumab (Opdivo®) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway, approved by the FDA for treatment of recurrent or metastatic head and neck squamous cell carcinoma and for subsets of patients with advanced head and neck cancer[4][9][11][12].
  • Dostarlimab (Jemperli) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway, approved for subsets of patients with advanced head and neck cancer that has DNA mismatch repair deficiency (dMMR)[12].

Ongoing Clinical Trials on Squamous cell carcinoma of head and neck

  • Testing the Safety and Effects of TUB-030 in Patients with Advanced Head and Neck Cancer or Non-Small-Cell Lung Cancer

    Recruiting

    1 1
    Investigated drugs:
    France Romania Spain
  • A study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Czechia France Germany Hungary +5
  • Study of nivolumab and ipilimumab immunotherapy for organ preservation in patients with advanced head and neck squamous cell carcinoma

    Recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands
  • Study of ivonescimab alone or with ligufalimab versus pembrolizumab for patients with recurrent or metastatic head and neck squamous cell cancer

    Recruiting

    1 1 1 1
    Belgium France Spain
  • Study of Pucotenlimab with Becotatug Vedotin versus Becotatug Vedotin alone for patients with locally advanced head and neck squamous cell carcinoma

    Recruiting

    1 1
    France
  • Study of Cetuximab and Paclitaxel for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Pembrolizumab Treatment

    Recruiting

    1 1 1
    Investigated drugs:
    Spain
  • Study of MC2 TCR T Cell Therapy and Epigenetic Drug Treatment for Patients with Advanced Melanoma or Head and Neck Cancer

    Recruiting

    1 1
    The Netherlands
  • Study on PET Imaging with Fianlimab and Cemiplimab for Patients with Advanced Solid Tumors, with or without Platinum-Based Chemotherapy

    Recruiting

    1 1 1
    Investigated drugs:
    The Netherlands
  • Study of Carboplatin, Paclitaxel, and Cetuximab for Patients with Recurrent or Metastatic Head and Neck Cancer After Pembrolizumab Treatment Failure

    Recruiting

    1 1 1
    France
  • Study on Pembrolizumab and Radiotherapy for Patients with Limited Spread of Head and Neck Cancer

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium Italy Spain

References

https://www.mdanderson.org/cancerwise/squamous-cell-carcinomas–8-things-to-know-about-the–cancer-of-the-surfaces.h00-159544479.html

https://www.cancer.gov/types/head-and-neck/head-neck-fact-sheet

https://medlineplus.gov/genetics/condition/head-and-neck-squamous-cell-carcinoma/

https://pmc.ncbi.nlm.nih.gov/articles/PMC7944998/

https://www.mayoclinic.org/diseases-conditions/head-and-neck-cancers/symptoms-causes/syc-20354171

https://www.nature.com/articles/s41572-020-00224-3

https://pubmed.ncbi.nlm.nih.gov/33243986/

https://www.yalemedicine.org/clinical-keywords/head-and-neck-squamous-cell-carcinoma

https://pmc.ncbi.nlm.nih.gov/articles/PMC9046875/

https://www.cancer.gov/types/head-and-neck/patient/adult/metastatic-squamous-neck-treatment-pdq

https://www.opdivo.com/head-and-neck-cancer

https://www.cancerresearch.org/immunotherapy-by-cancer-type/head-and-neck-cancer

https://www.mayoclinic.org/diseases-conditions/head-and-neck-cancers/diagnosis-treatment/drc-20558359

https://my.clevelandclinic.org/health/diseases/14458-head-and-neck-cancer

https://www.mdanderson.org/cancerwise/squamous-cell-carcinomas–8-things-to-know-about-the–cancer-of-the-surfaces.h00-159544479.html

https://www.mdanderson.org/cancerwise/squamous-cell-carcinomas–8-things-to-know-about-the–cancer-of-the-surfaces.h00-159544479.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC3851517/

https://my.clevelandclinic.org/health/diseases/14458-head-and-neck-cancer

https://news.cuanschutz.edu/cancer-center/what-to-know-about-head-and-neck-cancer

https://www.cancercare.org/publications/330-after_a_head_and_neck_cancer_diagnosis_questions_to_ask_your_health_care_team

https://www.mayoclinic.org/diseases-conditions/head-and-neck-cancers/diagnosis-treatment/drc-20558359

https://www.macmillan.org.uk/cancer-information-and-support/head-and-neck-cancer

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

What is the main difference between HPV-positive and HPV-negative head and neck cancer?

HPV-positive head and neck cancers are caused by infection with human papillomavirus and tend to occur in younger people, particularly affecting the middle part of the throat including the tonsils and base of tongue. These cancers generally have a more favorable prognosis compared to HPV-negative cancers, which are typically associated with tobacco and alcohol use[4][12].

Can head and neck cancer be prevented?

Many head and neck cancers are preventable. The most effective ways to reduce risk include avoiding tobacco products (including cigarettes, cigars, and chewing tobacco), limiting alcohol consumption, and getting vaccinated against HPV. The HPV vaccine is approved for preventing HPV-related head and neck cancers[2][3][12][14].

What are the most common symptoms of head and neck cancer?

The most common symptom is a persistent sore throat that does not improve. Other signs include a lump in the neck, throat, or mouth that does not heal, difficulty swallowing, pain when swallowing, hoarseness or voice changes, frequent nosebleeds, bloody saliva, persistent earaches, and swelling in the jaw or neck. Any of these symptoms lasting more than a few weeks should be evaluated by a healthcare provider[2][3][5][14].

How is head and neck cancer typically treated?

Treatment depends on the cancer’s location and stage. For cancers in the oral cavity (mouth), treatment typically involves surgery first, followed by chemotherapy and radiation if needed. For cancers in the throat and voice box, treatment often consists of chemotherapy combined with radiation without surgery. Advanced or metastatic cases may be treated with immunotherapy drugs like pembrolizumab or nivolumab[4][9].

Will I be able to speak and eat normally after treatment?

This depends on the location and extent of the cancer and the type of treatment received. Treatment teams work to preserve functions related to speaking, eating, and making facial expressions as much as possible. Some patients experience temporary difficulties that improve with time and rehabilitation, while others may have permanent changes requiring adjustments in how they communicate or eat. Speech therapy, swallowing therapy, and nutritional support can help patients adapt and maximize their functional abilities[4][17][5].

🎯 Key takeaways

  • Head and neck squamous cell carcinoma has a five-year survival rate of approximately 60%, with significantly better outcomes when detected early.
  • HPV-related head and neck cancers are increasing, especially in younger people, while tobacco-related cases are declining in the United States.
  • The disease can profoundly affect daily activities including eating, speaking, breathing, and social interactions due to its highly visible nature.
  • Most patients are diagnosed with late-stage disease because early changes often cause no noticeable symptoms or are mistaken for less serious conditions.
  • Treatment approaches vary by location—mouth cancers typically require surgery first, while throat and voice box cancers are often treated with chemotherapy and radiation.
  • Several FDA-approved immunotherapy drugs, including pembrolizumab and nivolumab, now offer important treatment options for recurrent or metastatic disease.
  • Family support is crucial throughout the cancer journey, from helping with clinical trial research to providing practical assistance with daily tasks and emotional support.
  • Psychosocial interventions, including counseling and support groups, can significantly improve quality of life and help patients cope with the emotional burden of the disease.